mktcap_usd=189773
ConsensRecom=2.20
earning_yield=6.16%
growth=0.78%
dilution=-1.47%
div_ratio=43.58%
sh_payout_ratio=66.76%
margin=22.56%
cfmargin=20.11%
ratiopaid=71.46%
sratiopaid=24.42%
ratioConsens=1.25
Description
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.
Income and Cashflow Statements USD
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-01-25 | 2020-01-29 | 2020-01-29 | 2020-01-29 | 2021-01-26 | 2022-02-02 | 2023-02-01 | NaN | NaN |
| period | 12M | 12M | 12M | 12M | 12M | 12M | 12M | NaN | NaN |
| rev | 49386 | 43361 | 46017 | 48624 | 49898 | 52877 | 51742 | 48844 | 3270 |
| revgrowth | NaN | -13.01% | 5.95% | 5.51% | 2.59% | 5.80% | -2.17% | 0.78% | 7.43% |
| earn | 6712 | 7703 | 12611 | 11732 | 8072 | 24021 | 6955 | 11115 | 6148 |
| earnx | 6712 | 7499 | 12797 | 7142 | 8072 | 24021 | 6955 | 10457 | 6340 |
| margin | 13.59% | 17.76% | 27.41% | 24.13% | 16.18% | 45.43% | 13.44% | 22.56% | 11.37% |
| xmargin | 13.59% | 17.29% | 27.81% | 14.69% | 16.18% | 45.43% | 13.44% | 21.20% | 11.77% |
| earningyld | NaN | NaN | 6.90% | 5.17% | 3.60% | 11.76% | 3.38% | 6.16% | 3.43% |
| cfop | 11475 | 12621 | 14272 | 13625 | 13650 | 15071 | 14236 | 13564 | 1189 |
| cfinv | -3441 | -3119 | -5591 | -2226 | -13182 | 4208 | 1468 | -3126 | 5523 |
| cffin | -5314 | -7733 | -4244 | -13627 | -2208 | -16264 | -20562 | -9993 | 6891 |
| cfopmargin | 23.24% | 29.11% | 31.01% | 28.02% | 27.36% | 28.50% | 27.51% | 27.82% | 2.37% |
| cfinvmargin | -6.97% | -7.19% | -12.15% | -4.58% | -26.42% | 7.96% | 2.84% | -6.64% | 11.02% |
| cffinmargin | -10.76% | -17.83% | -9.22% | -28.03% | -4.43% | -30.76% | -39.74% | -20.11% | 13.03% |
| shares | 2480 | 2450 | 2422 | 2396 | 2373 | 2335 | 2270 | 2390 | 71.2 |
| fx | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0 |
| price | NaN | NaN | 75.5 | 94.7 | 94.4 | 87.5 | 90.7 | 88.5 | 7.88 |
| dilution | NaN | -1.22% | -1.15% | -1.07% | -1.00% | -1.58% | -2.83% | -1.47% | 0.69% |
| dividend | 6475 | 6495 | 6966 | 6645 | 6987 | 7368 | 7506 | 6920 | 409 |
| sharebb | NaN | NaN | NaN | 2198 | 2247 | 3383 | 5799 | 3407 | 1686 |
| ltdebtbb | NaN | -5327 | 754 | 414 | -5922 | 3455 | 2741 | -648 | 4028 |
| mgtbb | NaN | NaN | NaN | -4370 | 1104 | -2058 | -4516 | -2460 | 2630 |
| divyld | NaN | NaN | 3.81% | 2.93% | 3.12% | 3.61% | 3.65% | 3.42% | 0.38% |
| sharebbyld | NaN | 1.22% | 1.15% | 1.07% | 1.00% | 1.58% | 2.83% | 1.47% | 0.69% |
| mgtyld | NaN | NaN | NaN | -1.93% | 0.49% | -1.01% | -2.19% | -1.16% | 1.21% |
Balance Sheet
| EndDate | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | mean | std |
|---|---|---|---|---|---|---|---|---|---|
| sourceDate | 2017-01-25 | 2020-01-29 | 2020-01-29 | 2020-01-29 | 2021-01-26 | 2022-02-02 | 2023-02-01 | NaN | NaN |
| mktcap | NaN | NaN | 182844 | 226911 | 224044 | 204276 | 205847 | 208784 | 17771 |
| mktcapgrowth | NaN | NaN | NaN | 21.59% | -1.27% | -9.24% | 0.77% | 2.96% | 13.15% |
| totAsset | 130124 | 133079 | 145563 | 118370 | 127778 | 131795 | 117453 | 129166 | 9554 |
| assetgrowth | NaN | 2.25% | 8.97% | -20.68% | 7.65% | 3.10% | -11.52% | -1.71% | 11.80% |
| curAsset | 24931 | 28208 | 35563 | 29504 | 29673 | 45718 | 36910 | 32930 | 7011 |
| curAssetPct | 19.16% | 21.20% | 24.43% | 24.93% | 23.22% | 34.69% | 31.43% | 25.58% | 5.55% |
| totLiab | 55292 | 58911 | 66949 | 62896 | 71180 | 64140 | 58111 | 62497 | 5509 |
| totLiabPct | 42.49% | 44.27% | 45.99% | 53.14% | 55.71% | 48.67% | 49.48% | 48.53% | 4.74% |
| curLiab | 22209 | 23403 | 29607 | 28264 | 33059 | 30208 | 28656 | 27915 | 3833 |
| curLiabPct | 17.07% | 17.59% | 20.34% | 23.88% | 25.87% | 22.92% | 24.40% | 21.72% | 3.44% |
| ltDebt | 17897 | 23224 | 22470 | 22056 | 27978 | 24523 | 21782 | 22847 | 3046 |
| ltDebtPct | 13.75% | 17.45% | 15.44% | 18.63% | 21.90% | 18.61% | 18.55% | 17.76% | 2.61% |
| Equity | 74832 | 74168 | 78614 | 55474 | 56598 | 67655 | 59342 | 66669 | 9548 |
| EquityPct | 57.51% | 55.73% | 54.01% | 46.86% | 44.29% | 51.33% | 50.52% | 51.47% | 4.74% |
| PB | NaN | NaN | 2.33 | 4.09 | 3.96 | 3.02 | 3.47 | 3.37 | 72.25% |
Beta
len=64.0
mean=3.76%
sd=17.38%
alpha=0.15%
beta=49.02%
r_sq=26.48%
lastdate=2023-03-17
firstdate=2018-04-30
logret1y=-6.55%
Financial Snapshot
CompanyName=Novartis AG (ADR)
ID=1
Name=ADR
Ticker=NVS
ISIN=None
RIC=NVS
DisplayRIC=NVS.N
InstrumentPI=301974
QuotePI=1096008
InstrumentPermID=8590926012
QuotePermID=55838324558
Exchange=New York Stock Exchange
ExchangeCode=NYSE
ExchangeCountry=USA
CoStatus=Active
CoType=Equity Issue
LastModified=2023-02-04
LatestAvailableAnnual=2022-12-31
LatestAvailableInterim=2022-12-31
Employees=101703
SharesOut=2.120e+09
TotalFloat=2.093e+09
ReportingCurrency=USD
MostRecentExchange=1.0
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
NPRICE=83.6
NHIG=94.3
NLOW=74.1
PDATE=2023-03-24
VOL10DAVG=2.56
EV=198752
MKTCAP=189773
AREV=51742
AEBITD=18455
ANIAC=6955
AEPSXCLXOR=3.16
AREVPS=23.6
ABVPS=28.0
ACSHPS=8.93
ACFSHR=5.65
ADIVSHR=3.33
AGROSMGN=71.0
AROEPCT=11.0
APR2REV=3.67
APEEXCLXOR=26.4
APRICE2BK=2.99
ConsRecom=2.20
TargetPrice=104
ProjLTGrowthRate=5.89
ProjPE=12.7
ProjSales=52388
ProjSalesQ=12650
ProjEPS=6.56
ProjEPSQ=1.54
ProjProfit=13452
ProjDPS=3.50
quoteccy=USD
quotefx=100.00%
exchgccy=USD
exchgfx=100.00%
tick=None
exchg=None
Valuation
ticker=NVS
exchg=AMEX
RIC=NVS
CompanyName=Novartis AG (ADR)
ExchangeCode=NYSE
Industry=Pharmaceuticals (NEC)
IndustryCode=5620104010
sector=56 Healthcare
region=us
ccy=USD
fx=100.00%
mktcap_usd=189773
float_usd=187384
ConsensRecom=2.20
earning_yield=6.16%
growth=0.78%
dilution=-1.47%
margin=22.56%
searning_yield=3.29%
sgrowth=-6.02%
smargin=12.03%
sdilution=-0.84%
projearning_yield=7.55%
earning_excl_yield=3.71%
div_ratio=43.58%
bb_ratio=23.18%
sh_payout_ratio=66.76%
PS=3.55
price=83.6
ratio=71.46%
sratio=24.42%
sratiopaid=24.42%
ratioConsens=1.25
turnover=38.06%
cfmargin=20.11%
rdmargin=17.38%
scfmargin=8.05%
quoteccy=USD
quotefx=100.00%
ratiopaid=71.46%
dt=2023-03-24
assetgrowth=-1.71%
dlnfx=0